Delivery Order SPE2DB22D3301-SPE2DB24FY9WF

Award Date 7/3/24
Potential Completion Date 7/5/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,042.10 to supply 4.2% sodium bicarbonate vials. The contract has a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
The U.S. Defense Logistics Agency (DLA) awarded a $6,326.66 firm-fixed-price delivery order contract for 4,565,095,664 units of 8.4% sodium bicarbonate vials (50 mL) to Amerisourcebergen Drug Corp's Corporate Office division. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4.2% sodium bicarbonate vials. The contract has a ceiling value of $8,615.94 and a period of performance through April 1, 2024. This delivery order falls under Amerisourcebergen's existing $999,999,999.00 indefinite delivery contract with DLA, which serves as the primary vehicle for the company to deliver...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,742.32 to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of 5ml vials of 4.2% sodium bicarbonate to support military treatment programs and facilities. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, which has a potential value...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4.2% sodium bicarbonate vials. The contract has a ceiling value of $1,042.10 and a performance period through April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,191.25 Firm Fixed Price Delivery Order is for the supply of 50 ml vials of 8.4% Sodium Bicarbonate, a critical medical product. The contract has a completion date of January 9, 2024 and was awarded on January 8, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award is for the supply of 4564334992 - SODIUM BICARBONATE 8.4% VIAL 50ML to the Defense Logistics Agency (DLA) by the prime contractor Amerisourcebergen Drug Corp. The $8,522.40 firm fixed-price delivery order contract has an ultimate completion date of April 22, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office Division. The $18,378.70 firm-fixed-price delivery order is for the supply of 4,564,730,817 units of 8.4% sodium bicarbonate syringes in 50 ml containers. The contract has a period of performance through May 29, 2024 and was awarded on May 28, 2024. This award is part of Amerisourcebergen's existing Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 8.4% sodium bicarbonate vials, 50 ml, with a ceiling value of $3,334.19 and a period of performance through November 14, 2024. The contract is a firm fixed price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,401.09, is for the delivery of sodium bicarbonate 8.4% vials, 50 ml in size. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY9WF
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of sodium bicarbonate 4.2% vials (10 mL) to the Defense Logistics Agency (DLA). The $2,377.86 delivery order is a firm fixed-price contract with a completion date of July 5, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract does not have a set-aside designation.

Generated 10/2/24, 10:59 AM